Security key
90240B106
Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share (TYRA)
CUSIP: 90240B106
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 58,928,571
- Total 13F shares
- 35,744,229
- Share change
- -387,251
- Total reported value
- $255,572,000
- Price per share
- $7.15
- Number of holders
- 44
- Value change
- -$3,322,156
- Number of buys
- 21
- Number of sells
- 18
Report period
Q2 2022
Institutions
44
Top holders
10
TYRA full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Tyra Biosciences, Inc. SEC filings
Tyra Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90240B106
Recent filing periods:
Top shareholders of TYRA - Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
13F
3/4/5
Large-stake signal
No latest 13D/G holder appears in this grouped view.
Evidence coverage
49 holder rows
Latest evidence as of 16 May 2022.
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
12%
|
$77,430,000
7,236,454 shares
|
— | 31 Mar 2022 |
| Boxer Capital, LLC |
13F
Company
|
11%
|
$68,997,000
6,448,359 shares
|
— | 31 Mar 2022 |
| Canaan Partners XI LLC |
13F
Company
|
7.5%
|
$47,187,000
4,409,991 shares
|
— | 31 Mar 2022 |
| FMR LLC |
13F
Company
|
6.9%
|
$43,764,000
4,090,085 shares
|
— | 31 Mar 2022 |
| Nextech Invest Ltd. |
13F
Company
|
4.3%
|
$26,949,000
2,518,582 shares
|
— | 31 Mar 2022 |
| BVF INC/IL |
13F
Company
|
4.2%
|
$26,454,000
2,472,327 shares
|
— | 31 Mar 2022 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
2.3%
|
$14,206,000
1,327,665 shares
|
— | 31 Mar 2022 |
| Fairmount Funds Management LLC |
13F
Company
|
2.2%
|
$13,749,000
1,284,990 shares
|
— | 31 Mar 2022 |
| JANUS HENDERSON GROUP PLC |
13F
Company
|
1.5%
|
$9,718,000
909,192 shares
|
— | 31 Mar 2022 |
| TCG Crossover Management, LLC |
13F
Company
|
1.5%
|
$9,592,000
896,418 shares
|
— | 31 Mar 2022 |
| Cormorant Asset Management, LP |
13F
3/4/5
Company · Former 10% Owner
|
1.3%
|
$8,105,000
757,432 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
0.99%
|
$6,242,000
583,236 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
0.88%
|
$5,517,000
515,637 shares
|
— | 31 Mar 2022 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
0.84%
|
$5,290,000
494,403 shares
|
— | 31 Mar 2022 |
| Woodline Partners LP |
13F
Company
|
0.45%
|
$2,848,000
266,161 shares
|
— | 31 Mar 2022 |
| Logos Global Management LP |
13F
Company
|
0.43%
|
$2,704,000
252,726 shares
|
— | 31 Mar 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
0.43%
|
$2,688,000
251,222 shares
|
— | 31 Mar 2022 |
| JPMORGAN CHASE & CO |
13F
Company
|
0.39%
|
$2,445,000
228,482 shares
|
— | 31 Mar 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.36%
|
$2,252,000
210,549 shares
|
— | 31 Mar 2022 |
| STATE STREET CORP |
13F
Company
|
0.35%
|
$2,179,000
203,680 shares
|
— | 31 Mar 2022 |
| Ensign Peak Advisors, Inc |
13F
Company
|
0.21%
|
$1,338,000
125,000 shares
|
— | 31 Mar 2022 |
| Sio Capital Management, LLC |
13F
Company
|
0.19%
|
$1,188,000
111,033 shares
|
— | 31 Mar 2022 |
| NORTHERN TRUST CORP |
13F
Company
|
0.17%
|
$1,071,000
100,104 shares
|
— | 31 Mar 2022 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
0.14%
|
$893,000
83,438 shares
|
— | 31 Mar 2022 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
0.14%
|
$861,000
80,456 shares
|
— | 31 Mar 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.13%
|
$838,000
78,309 shares
|
— | 31 Mar 2022 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.11%
|
$686,000
64,126 shares
|
— | 31 Mar 2022 |
| Bank of New York Mellon Corp |
13F
Company
|
0.05%
|
$328,000
30,620 shares
|
— | 31 Mar 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.05%
|
$314,000
29,300 shares
|
— | 31 Mar 2022 |
| Nuveen Asset Management, LLC |
13F
Company
|
0.03%
|
$197,000
18,400 shares
|
— | 31 Mar 2022 |
| RHUMBLINE ADVISERS |
13F
Company
|
0.02%
|
$125,000
11,726 shares
|
— | 31 Mar 2022 |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
Company
|
0.02%
|
$113,000
10,517 shares
|
— | 31 Mar 2022 |
| DEUTSCHE BANK AG\ |
13F
Company
|
0.01%
|
$71,000
6,613 shares
|
— | 31 Mar 2022 |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
Company
|
0.01%
|
$63,000
5,856 shares
|
— | 31 Mar 2022 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
Company
|
0.01%
|
$54,000
5,064 shares
|
— | 31 Mar 2022 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0%
|
$27,000
2,562 shares
|
— | 31 Mar 2022 |
| BARCLAYS PLC |
13F
Company
|
0%
|
$20,000
1,915 shares
|
— | 31 Mar 2022 |
| AMALGAMATED BANK |
13F
Company
|
0%
|
$19,000
1,771 shares
|
— | 31 Mar 2022 |
| Amalgamated Financial Corp. |
13F
Company
|
0%
|
$19,000
1,771 shares
|
— | 31 Mar 2022 |
| UBS Group AG |
13F
Company
|
0%
|
$19,000
1,740 shares
|
— | 31 Mar 2022 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$16,000
1,571 shares
|
— | 31 Mar 2022 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$13,000
1,243 shares
|
— | 31 Mar 2022 |
| Legal & General Group Plc |
13F
Company
|
0%
|
$12,000
1,126 shares
|
— | 31 Mar 2022 |
| Ameritas Investment Partners, Inc. |
13F
Company
|
0%
|
$10,000
940 shares
|
— | 31 Mar 2022 |
| ROYAL BANK OF CANADA |
13F
Company
|
0%
|
$8,000
725 shares
|
— | 31 Mar 2022 |
| CITIGROUP INC |
13F
Company
|
0%
|
$5,000
459 shares
|
— | 31 Mar 2022 |
| Alta Partners NextGen Fund II Management, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$26,844,267
4,080,296 shares
|
— | 17 Sep 2021 |
| Canaan XI L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$3,114,472
473,396 shares
|
— | 17 Sep 2021 |
| Ali D. Fawaz |
3/4/5
General Counsel and Secretary
|
—
class O/S missing
|
—
361,586 shares
|
— | 16 May 2022 |
Institutional Holders of Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share (TYRA) as of Q2 2022
As of 30 Jun 2022,
Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share (TYRA) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,744,229 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, Canaan Partners XI LLC, FMR LLC, Nextech Invest AG, BVF INC/IL, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., TCG Crossover Management, LLC, and Cormorant Asset Management, LP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
46
Q2 2022 holders
44
Holder diff
-2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.